Metabolites in the regulatory risk assessment of pesticides in the EU.

analytical methods disproportionate human metabolite in vitro/in silico testing pesticide metabolite risk assessment unique human metabolite xenobiotic metabolism

Journal

Frontiers in toxicology
ISSN: 2673-3080
Titre abrégé: Front Toxicol
Pays: Switzerland
ID NLM: 101777990

Informations de publication

Date de publication:
2023
Historique:
received: 30 09 2023
accepted: 30 11 2023
medline: 8 1 2024
pubmed: 8 1 2024
entrez: 8 1 2024
Statut: epublish

Résumé

A large majority of chemicals is converted into metabolites through xenobiotic-metabolising enzymes. Metabolites may present a spectrum of characteristics varying from similar to vastly different compared with the parent compound in terms of both toxicokinetics and toxicodynamics. In the pesticide arena, the role of metabolism and metabolites is increasingly recognised as a significant factor particularly for the design and interpretation of mammalian toxicological studies and in the toxicity assessment of pesticide/metabolite-associated issues for hazard characterization and risk assessment purposes, including the role of metabolites as parts in various residues in ecotoxicological adversities. This is of particular relevance to pesticide metabolites that are unique to humans in comparison with metabolites found in

Identifiants

pubmed: 38188093
doi: 10.3389/ftox.2023.1304885
pii: 1304885
pmc: PMC10770266
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1304885

Informations de copyright

Copyright © 2023 Pelkonen, Abass, Parra Morte, Panzarea, Testai, Rudaz, Louisse, Gundert-Remy, Wolterink, Jean-Lou CM, Coecke and Bernasconi.

Déclaration de conflit d'intérêts

JoL, JeL, MP and JP were employed by the European Food Safety Authority (EFSA). SC and CB were employed by the European Commission Joint Research Centre (JRC). The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Auteurs

Olavi Pelkonen (O)

Research Unit of Biomedicine, Pharmacology and Toxicology, University of Oulu, Oulu, Finland.

Khaled Abass (K)

Department of Environmental Health Sciences, College of Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.
Sharjah Institute for Medical Research (SIMR), University of Sharjah, Sharjah, United Arab Emirates.
Research Unit of Biomedicine and Internal Medicine, Faculty of Medicine, University of Oulu, Oulu, Finland.

Juan Manuel Parra Morte (JM)

EFSA, European Food Safety Authority, Parma, Italy.

Martina Panzarea (M)

EFSA, European Food Safety Authority, Parma, Italy.

Emanuela Testai (E)

Mechanisms, Biomarkers and Models Unit, Environment and Health Department, Istituto Superiore di Sanità, Rome, Italy.

Serge Rudaz (S)

School of Pharmaceutical Sciences, University of Geneva, CMU, Geneva, Switzerland.

Jochem Louisse (J)

EFSA, European Food Safety Authority, Parma, Italy.
Wageningen Food Safety Research (WFSR), Wageningen, Netherlands.

Ursula Gundert-Remy (U)

Institute of Clinical Pharmacology and Toxicology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.

Gerrit Wolterink (G)

Centre for Prevention, Lifestyle and Health, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.

Dorne Jean-Lou Cm (D)

EFSA, European Food Safety Authority, Parma, Italy.

Sandra Coecke (S)

European Commission, Joint Research Centre (JRC), Ispra, Italy.

Camilla Bernasconi (C)

European Commission, Joint Research Centre (JRC), Ispra, Italy.

Classifications MeSH